search
Back to results

Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf) (MCTf)

Primary Purpose

Psychosis, Mother-Child Relations

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Familiar Metacognitive Training
Sponsored by
Fundació Sant Joan de Déu
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Psychosis

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Presence of one of the following diagnoses according to DSM-V criteria: schizophrenia, unspecific psychotic disorder, schizoaffective disorder, delusional disorder, brief psychotic disorder, schizophreniform disorder.
  • Mother of one o more adolescent (12-18 years old).
  • Psychopatological stability in the previous 3 months.(without medication changes).

Exclusion Criteria:

  • Head injury or intellectual disabillity (premorbid IQ <=70)
  • Present scores on the PANSS >= hostility, lack of cooperation or suspiciousness, to guarantee a good relationship in the group.
  • Patients with substance dependence disorder.

Inclusion/exclusion criteria of adolescents are: 1.age between 12 and 18 yerars old, 2. interested in the group. Exclusion criteria: Head injury or intellectual disabillity (premorbid IQ <=70).

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Online Familiar Metacognitive Training

    Control group

    Arm Description

    Metacognitive training for psychosis. The MCTf consists of 11 therapeutic units developed during weekly sessions lasting 45 and 60 minutes. Each unit contains abundant therapeutic material that includes psychoeducational information, exercises and case examples.The group will be composed of 3-4 mothers with psychosis and her adolescent children and two therapists. The application of the intervention will be by a secure videoconfering method.

    The control group will be receive treatment as usual (TAU).

    Outcomes

    Primary Outcome Measures

    BCIS Beck Cognitive and Insight Scale (Beck et al., 2004; Gutierrez-Zotes et al., 2012)
    This scales is a self-registering measure of 15 items. It has 2 dimensions:self-reflection and self-certaintly. A compound index of cognitive insight is obtained as the substraction of self-certaintly from self-reflection.Range 0-45. Higher values represent a better outcome.
    BCIS Beck Cognitive and Insight Scale (Beck et al., 2004; Gutierrez-Zotes et al., 2012)
    This scales is a self-registering measure of 15 items. It has 2 dimensions:self-reflection and self-certaintly. A compound index of cognitive insight is obtained as the substraction of self-certaintly from self-reflection.Range 0-45. Higher values represent a better outcome.

    Secondary Outcome Measures

    CBQ Cognitive Biais Questionnaire (Peters et al., 2013; Guiterrez-Zotes et al.,2021
    Scale for the assessment of the most cognitive biases in psychosis.Higher values represent more biases.
    CBQ Cognitive Biais Questionnaire (Peters et al., 2013; Guiterrez-Zotes et al.,2021
    Scale for the assessment of the most cognitive biases in psychosis. Higher values represent more biases.
    Jumping to conclusions (Garety et al., 1991; Dudley et al., 1997)
    Scale for the assessment to the Jumping to conclusions bias. 3 tasks will be included. JTC is considered if the decision is taken before the third ball.
    Jumping to conclusions (Garety et al., 1991; Dudley et al., 1997)
    Scale for the assessment to the Jumping to conclusions bias. 3 tasks will be included. JTC is considered if the decision is taken before the third ball.
    IPSAQ, Internal, personal and situational Attributions Questionnaire.(Bentall et al., 1991; Diez-Alegria, 2006)
    The scale assess the attributional style in different situations.There are no ranges.
    IPSAQ, Internal, personal and situational Attributions Questionnaire.(Bentall et al., 1991; Diez-Alegria, 2006)
    The scale assess the attributional style in different situations.There are no ranges.
    The Hinting Task (Corcoran et al., 1995; Gil et al., 2012)
    The scale asses Theory of Mind. Possible Range 0-12. Higher values represent a better outcome.
    The Hinting Task (Corcoran et al., 1995; Gil et al., 2012)
    The scale asses Theory of Mind. Possible Range 0-12. Higher values represent a better outcome.
    Face Test (Baron Cohen, 1997; Huerta-Ramos et al., 2021)
    20 photographs that express ten basic and ten complex emotions. Possible range 0-20. Higher values representa better outcome.
    Face Test (Baron Cohen, 1997; Huerta-Ramos et al., 2021)
    20 photographs that express ten basic and ten complex emotions. Possible range 0-20. Higher values representa better outcome.
    SFRT-2 .Situational feature recognition test 2 (Gomez-Gastiasoro et al., 2018)
    The scales assess social perception. There are no ranges
    SFRT-2 .Situational feature recognition test 2 (Gomez-Gastiasoro et al., 2018)
    The scales assess social perception. There are no ranges
    FES Family Enviromental Scale (Moos et al., 1987; Fernandez-Ballesteros., 1995)
    The scale include 3 dimensions: relationships, development and stability.
    FES Family Enviromental Scale (Moos et al., 1987; Fernandez-Ballesteros., 1995)
    The scale include 3 dimensions: relationships, development and stability.
    SWLS Satisfaction with life style (Pons et al., 2002)
    The scale asses the degree of satisfaction of the person with their life in 5 items. Self-administered.
    SWLS Satisfaction with life style (Pons et al., 2002)
    The scale asses the degree of satisfaction of the person with their life in 5 items. Self-administered.
    PANSS.Positive and Negative Syndrome Scale (Kay et al., 1987; Peralta and Cuesta., 1994)
    This scale measure 30 symptoms on a scale 1-7, with higher scores indicating greater psychopathology
    PANSS.Positive and Negative Syndrome Scale (Kay et al., 1987; Peralta and Cuesta., 1994)
    This scale measure 30 symptoms on a scale 1-7, with higher scores indicating greater psychopathology
    CDSS. Calgary Depression Scale for Schizophrenia (Addington et al., 1990)
    The scale assess affective symptoms. Higher values indicate more symptoms.
    CDSS. Calgary Depression Scale for Schizophrenia (Addington et al., 1990)
    The scale assess affective symptoms. Higher values indicate more symptoms.
    SUMD. Scale of Unaweressness of Mental Disorder (Amador., 1993; Ruiz et al., 2008)
    The scale assess awareness of illness in people with schizophrenia, according to the evaluator´s vision
    SUMD. Scale of Unaweressness of Mental Disorder (Amador., 1993; Ruiz et al., 2008)
    The scale assess awareness of illness in people with schizophrenia, according to the evaluator´s vision
    EEAG-Scale of Functioning (Endicot et al., 1976)
    This scale measures the general functioning of the patient on a scale that ranges from 0 to 100.
    EEAG-Scale of Functioning (Endicot et al., 1976)
    This scale measures the general functioning of the patient on a scale that ranges from 0 to 100.
    Rosenberg Self-Esteem Scale (Martín Albó et al., 2007)
    Questionnaire to explore personal self-esteem understood as feelings of personal worth and self-respect. The scale consist of 10 items.
    Rosenberg Self-Esteem Scale (Martín Albó et al., 2007)
    Questionnaire to explore personal self-esteem understood as feelings of personal worth and self-respect. The scale consist of 10 items.
    CD Risk 17 (Serrano et al., 2013)
    The scale assess resilience with a total of 17 items.
    Coping Strategies Inventory (Tolbin et al., 1989; Cano et al; 2007)
    The scale includes 8 scales that assess the frequency of use of primary coping strategies and the perception of coping self-efficacy.
    Coping Strategies Inventory (Tolbin et al., 1989; Cano et al; 2007)
    The scale includes 8 scales that assess the frequency of use of primary coping strategies and the perception of coping self-efficacy.
    SSQ Self Stigma Questionnaire (Ochoa et al.,2015)
    The scales assess self-stigma. It consists of 14 items and is self-administered
    SSQ Self Stigma Questionnaire (Ochoa et al.,2015)
    The scales assess self-stigma. It consists of 14 items and is self-administered
    PAM Psychosis Attachment Measure (Berry et al., 2006; Sheinbaum et al., 2013)
    The scale assess attachment styles
    CTQ-SF Childhood Trauma Questionnaire (Bernstein et al., 1994; Hernández et al., 2012)
    The self-report includes a 28-item test that measures 5 types of maltreatment - emotional, physical, and sexual abuse, and emotional and physical neglect.
    YSR Youth Self-Report (Achembach., 1991; Lemos et al., 2002)
    It is an instrument to assess symptoms in adolescents between 11 and 18 years old.
    YSR Youth Self-Report (Achembach., 1991; Lemos et al., 2002)
    It is an instrument to assess symptoms in adolescents between 11 and 18 years old.
    KASI The Knowledge About Schizophrenia Interview
    Scale to asses the beliefs of the disorder
    KASI The Knowledge About Schizophrenia Interview
    Scale to asses the beliefs of the disorder

    Full Information

    First Posted
    April 1, 2022
    Last Updated
    May 2, 2022
    Sponsor
    Fundació Sant Joan de Déu
    Collaborators
    Parc Sanitari Sant Joan de Déu, Hospital de Sant Pau, Institut Pere Mata, Parc Taulí Hospital Universitari, Hospital de Mataró, Centre d'Higiene Mental Les Corts, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Hospital del Mar, Hospital Universitario Marqués de Valdecilla, Hospitales Universitarios Virgen del Rocío, Fundació Vidal i Barraquer, Hospital Sant Joan de Deu
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05358457
    Brief Title
    Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf)
    Acronym
    MCTf
    Official Title
    Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf) in Mothers With Psychosis and Their Adolescent Children
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 2022 (Anticipated)
    Primary Completion Date
    December 2025 (Anticipated)
    Study Completion Date
    December 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Fundació Sant Joan de Déu
    Collaborators
    Parc Sanitari Sant Joan de Déu, Hospital de Sant Pau, Institut Pere Mata, Parc Taulí Hospital Universitari, Hospital de Mataró, Centre d'Higiene Mental Les Corts, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Hospital del Mar, Hospital Universitario Marqués de Valdecilla, Hospitales Universitarios Virgen del Rocío, Fundació Vidal i Barraquer, Hospital Sant Joan de Deu

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    The objective of this study is to adapt and evaluate the efficacy of Familiar Metacognitive Training (MCTf) in mothers and adolescent children in a group context with the main purpose of improving family relationships, cognitive awareness and symptoms of women with psychosis and the knowledge of the disease by the children. Secondary objectives: to evaluate the improvement in metacognition and social cognition, symptoms, protective factors and self-perception of stigma.
    Detailed Description
    This is a randomized clinical trial will be carried out in which a group of mothers with psychosis and their adolescent children (between 12 and 18 years old) will receive the MCTf online and the other group will receive the treatment as usual. In total, 48 mothers and their children will be recruited from a total of 11 adult mental health care centers. Mothers will be evaluated with cognitive insight scales, other metacognitive and social cognition scales, symptoms, family and social functioning, protective factors (self-steem, resilience, and coping strategies) and self-perceived stigma. The adolescent children will be evaluated with symptoms, metacognition and social cognition, family and social functioning, knowledge of the mother´s illness and protective factors scales. The will be assessed at 2 times: baseline and post-therapy. The Metacognitive training is a group psychological intervention that has demonstrated its efficacy in improve symptoms, insight, metacognition and cognition in people with psychosis. Our hypothesis is that MCTf will be help the adolescents to better understand their mother´s thoughts and their understanding of metacognition and, consequently, to decrease anxiety and depressive symptoms.Furthermore, the investigators expect an increase in familiar and social functioning, as well as in protective factors such as: self-steem, resilience and coping strategies.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Psychosis, Mother-Child Relations

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Parrallel Assigment. This is a randomized clinical trial in which some patients receive the MCTf intervention and others treatment as usual
    Masking
    Outcomes Assessor
    Masking Description
    The evaluator will be blind to the group that ows the patients included
    Allocation
    Randomized
    Enrollment
    48 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Online Familiar Metacognitive Training
    Arm Type
    Experimental
    Arm Description
    Metacognitive training for psychosis. The MCTf consists of 11 therapeutic units developed during weekly sessions lasting 45 and 60 minutes. Each unit contains abundant therapeutic material that includes psychoeducational information, exercises and case examples.The group will be composed of 3-4 mothers with psychosis and her adolescent children and two therapists. The application of the intervention will be by a secure videoconfering method.
    Arm Title
    Control group
    Arm Type
    No Intervention
    Arm Description
    The control group will be receive treatment as usual (TAU).
    Intervention Type
    Behavioral
    Intervention Name(s)
    Familiar Metacognitive Training
    Intervention Description
    The original metacognitive training program consist of 8 therapeutic units and 2 complementary. Seven of the therapeutic units address cognitive deviations and errors that are frequently seen in problem solving in schizophrenia, involved in the formation and maintenance of delusions. The other three units work with metacognition and the aims of the progra, as a psychoeducation session, so in total the MCTf will include 11 sessions.
    Primary Outcome Measure Information:
    Title
    BCIS Beck Cognitive and Insight Scale (Beck et al., 2004; Gutierrez-Zotes et al., 2012)
    Description
    This scales is a self-registering measure of 15 items. It has 2 dimensions:self-reflection and self-certaintly. A compound index of cognitive insight is obtained as the substraction of self-certaintly from self-reflection.Range 0-45. Higher values represent a better outcome.
    Time Frame
    baseline
    Title
    BCIS Beck Cognitive and Insight Scale (Beck et al., 2004; Gutierrez-Zotes et al., 2012)
    Description
    This scales is a self-registering measure of 15 items. It has 2 dimensions:self-reflection and self-certaintly. A compound index of cognitive insight is obtained as the substraction of self-certaintly from self-reflection.Range 0-45. Higher values represent a better outcome.
    Time Frame
    up to 11 weeks
    Secondary Outcome Measure Information:
    Title
    CBQ Cognitive Biais Questionnaire (Peters et al., 2013; Guiterrez-Zotes et al.,2021
    Description
    Scale for the assessment of the most cognitive biases in psychosis.Higher values represent more biases.
    Time Frame
    baseline
    Title
    CBQ Cognitive Biais Questionnaire (Peters et al., 2013; Guiterrez-Zotes et al.,2021
    Description
    Scale for the assessment of the most cognitive biases in psychosis. Higher values represent more biases.
    Time Frame
    up to 11 weeks
    Title
    Jumping to conclusions (Garety et al., 1991; Dudley et al., 1997)
    Description
    Scale for the assessment to the Jumping to conclusions bias. 3 tasks will be included. JTC is considered if the decision is taken before the third ball.
    Time Frame
    baseline
    Title
    Jumping to conclusions (Garety et al., 1991; Dudley et al., 1997)
    Description
    Scale for the assessment to the Jumping to conclusions bias. 3 tasks will be included. JTC is considered if the decision is taken before the third ball.
    Time Frame
    up to 11 weeks
    Title
    IPSAQ, Internal, personal and situational Attributions Questionnaire.(Bentall et al., 1991; Diez-Alegria, 2006)
    Description
    The scale assess the attributional style in different situations.There are no ranges.
    Time Frame
    baseline
    Title
    IPSAQ, Internal, personal and situational Attributions Questionnaire.(Bentall et al., 1991; Diez-Alegria, 2006)
    Description
    The scale assess the attributional style in different situations.There are no ranges.
    Time Frame
    up to 11 weeks
    Title
    The Hinting Task (Corcoran et al., 1995; Gil et al., 2012)
    Description
    The scale asses Theory of Mind. Possible Range 0-12. Higher values represent a better outcome.
    Time Frame
    baseline
    Title
    The Hinting Task (Corcoran et al., 1995; Gil et al., 2012)
    Description
    The scale asses Theory of Mind. Possible Range 0-12. Higher values represent a better outcome.
    Time Frame
    up to 11 weeks
    Title
    Face Test (Baron Cohen, 1997; Huerta-Ramos et al., 2021)
    Description
    20 photographs that express ten basic and ten complex emotions. Possible range 0-20. Higher values representa better outcome.
    Time Frame
    baseline
    Title
    Face Test (Baron Cohen, 1997; Huerta-Ramos et al., 2021)
    Description
    20 photographs that express ten basic and ten complex emotions. Possible range 0-20. Higher values representa better outcome.
    Time Frame
    after the intervention
    Title
    SFRT-2 .Situational feature recognition test 2 (Gomez-Gastiasoro et al., 2018)
    Description
    The scales assess social perception. There are no ranges
    Time Frame
    baseline
    Title
    SFRT-2 .Situational feature recognition test 2 (Gomez-Gastiasoro et al., 2018)
    Description
    The scales assess social perception. There are no ranges
    Time Frame
    up to 11 weeks
    Title
    FES Family Enviromental Scale (Moos et al., 1987; Fernandez-Ballesteros., 1995)
    Description
    The scale include 3 dimensions: relationships, development and stability.
    Time Frame
    baseline
    Title
    FES Family Enviromental Scale (Moos et al., 1987; Fernandez-Ballesteros., 1995)
    Description
    The scale include 3 dimensions: relationships, development and stability.
    Time Frame
    up to 11 weeks
    Title
    SWLS Satisfaction with life style (Pons et al., 2002)
    Description
    The scale asses the degree of satisfaction of the person with their life in 5 items. Self-administered.
    Time Frame
    baseline
    Title
    SWLS Satisfaction with life style (Pons et al., 2002)
    Description
    The scale asses the degree of satisfaction of the person with their life in 5 items. Self-administered.
    Time Frame
    up to 11 weeks
    Title
    PANSS.Positive and Negative Syndrome Scale (Kay et al., 1987; Peralta and Cuesta., 1994)
    Description
    This scale measure 30 symptoms on a scale 1-7, with higher scores indicating greater psychopathology
    Time Frame
    baseline
    Title
    PANSS.Positive and Negative Syndrome Scale (Kay et al., 1987; Peralta and Cuesta., 1994)
    Description
    This scale measure 30 symptoms on a scale 1-7, with higher scores indicating greater psychopathology
    Time Frame
    up to 11 weeks
    Title
    CDSS. Calgary Depression Scale for Schizophrenia (Addington et al., 1990)
    Description
    The scale assess affective symptoms. Higher values indicate more symptoms.
    Time Frame
    baseline
    Title
    CDSS. Calgary Depression Scale for Schizophrenia (Addington et al., 1990)
    Description
    The scale assess affective symptoms. Higher values indicate more symptoms.
    Time Frame
    up to 11 weeks
    Title
    SUMD. Scale of Unaweressness of Mental Disorder (Amador., 1993; Ruiz et al., 2008)
    Description
    The scale assess awareness of illness in people with schizophrenia, according to the evaluator´s vision
    Time Frame
    baseline
    Title
    SUMD. Scale of Unaweressness of Mental Disorder (Amador., 1993; Ruiz et al., 2008)
    Description
    The scale assess awareness of illness in people with schizophrenia, according to the evaluator´s vision
    Time Frame
    up to 11 weeks
    Title
    EEAG-Scale of Functioning (Endicot et al., 1976)
    Description
    This scale measures the general functioning of the patient on a scale that ranges from 0 to 100.
    Time Frame
    baseline
    Title
    EEAG-Scale of Functioning (Endicot et al., 1976)
    Description
    This scale measures the general functioning of the patient on a scale that ranges from 0 to 100.
    Time Frame
    up to 11 weeks
    Title
    Rosenberg Self-Esteem Scale (Martín Albó et al., 2007)
    Description
    Questionnaire to explore personal self-esteem understood as feelings of personal worth and self-respect. The scale consist of 10 items.
    Time Frame
    baseline
    Title
    Rosenberg Self-Esteem Scale (Martín Albó et al., 2007)
    Description
    Questionnaire to explore personal self-esteem understood as feelings of personal worth and self-respect. The scale consist of 10 items.
    Time Frame
    up to 11 weeks
    Title
    CD Risk 17 (Serrano et al., 2013)
    Description
    The scale assess resilience with a total of 17 items.
    Time Frame
    baseline
    Title
    Coping Strategies Inventory (Tolbin et al., 1989; Cano et al; 2007)
    Description
    The scale includes 8 scales that assess the frequency of use of primary coping strategies and the perception of coping self-efficacy.
    Time Frame
    baseline
    Title
    Coping Strategies Inventory (Tolbin et al., 1989; Cano et al; 2007)
    Description
    The scale includes 8 scales that assess the frequency of use of primary coping strategies and the perception of coping self-efficacy.
    Time Frame
    up to 11 weeks
    Title
    SSQ Self Stigma Questionnaire (Ochoa et al.,2015)
    Description
    The scales assess self-stigma. It consists of 14 items and is self-administered
    Time Frame
    baseline
    Title
    SSQ Self Stigma Questionnaire (Ochoa et al.,2015)
    Description
    The scales assess self-stigma. It consists of 14 items and is self-administered
    Time Frame
    up to 11 weeks
    Title
    PAM Psychosis Attachment Measure (Berry et al., 2006; Sheinbaum et al., 2013)
    Description
    The scale assess attachment styles
    Time Frame
    baseline
    Title
    CTQ-SF Childhood Trauma Questionnaire (Bernstein et al., 1994; Hernández et al., 2012)
    Description
    The self-report includes a 28-item test that measures 5 types of maltreatment - emotional, physical, and sexual abuse, and emotional and physical neglect.
    Time Frame
    baseline
    Title
    YSR Youth Self-Report (Achembach., 1991; Lemos et al., 2002)
    Description
    It is an instrument to assess symptoms in adolescents between 11 and 18 years old.
    Time Frame
    baseline
    Title
    YSR Youth Self-Report (Achembach., 1991; Lemos et al., 2002)
    Description
    It is an instrument to assess symptoms in adolescents between 11 and 18 years old.
    Time Frame
    up to 11 weeks
    Title
    KASI The Knowledge About Schizophrenia Interview
    Description
    Scale to asses the beliefs of the disorder
    Time Frame
    baseline
    Title
    KASI The Knowledge About Schizophrenia Interview
    Description
    Scale to asses the beliefs of the disorder
    Time Frame
    up to 11 weeks
    Other Pre-specified Outcome Measures:
    Title
    WAIS-IV (Weschler Adults Intelligence Scale, 1955)
    Description
    vocabulary subscale to explore premorbid IQ
    Time Frame
    baseline
    Title
    TMT-A Trail Making Test, Retain, 1993
    Description
    Visual attention and task switching. Higher values represent a worse outcome.
    Time Frame
    baseline
    Title
    TMT-A Trail Making Test, Retain, 1993
    Description
    Visual attention and task switching. Higher values represent a worse outcome.
    Time Frame
    up to 11 weeks
    Title
    TMT-B Trail Making Test, Retain, 1993
    Description
    Visual attention and task switching. Higher values represent a worse outcome.
    Time Frame
    baseline
    Title
    TMT-B Trail Making Test, Retain, 1993
    Description
    Visual attention and task switching. Higher values represent a worse outcome.
    Time Frame
    up to 11 weeks
    Title
    WAIS-IV (Weschler Adults Intelligence Scale, 1955)
    Description
    Digits subscale. Higher values represent a better outcome.
    Time Frame
    baseline
    Title
    WAIS-IV (Weschler Adults Intelligence Scale, 1955)
    Description
    Digits subscale. Higher values represent a better outcome.
    Time Frame
    up to 11 weeks

    10. Eligibility

    Sex
    Female
    Gender Based
    Yes
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Presence of one of the following diagnoses according to DSM-V criteria: schizophrenia, unspecific psychotic disorder, schizoaffective disorder, delusional disorder, brief psychotic disorder, schizophreniform disorder. Mother of one o more adolescent (12-18 years old). Psychopatological stability in the previous 3 months.(without medication changes). Exclusion Criteria: Head injury or intellectual disabillity (premorbid IQ <=70) Present scores on the PANSS >= hostility, lack of cooperation or suspiciousness, to guarantee a good relationship in the group. Patients with substance dependence disorder. Inclusion/exclusion criteria of adolescents are: 1.age between 12 and 18 yerars old, 2. interested in the group. Exclusion criteria: Head injury or intellectual disabillity (premorbid IQ <=70).
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Susana Ochoa, Phd
    Phone
    936406350
    Ext
    12538
    Email
    susana.ochoa@sjd.es
    First Name & Middle Initial & Last Name or Official Title & Degree
    Raquel Lopez, Msc
    Email
    raquel.lopezc@sjd.es
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Susana Ochoa, Phd
    Organizational Affiliation
    Parc Sanitari Sant Joan de Deu
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf)

    We'll reach out to this number within 24 hrs